Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.

Disc Medicine, Inc.

Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. We are building a unique portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.

OrbiMed

Access Biotechnology

Bain Capital Life Sciences

Novo Holdings

Janus Henderson Investors

Rock Springs Capital

5AM Ventures

Arix Bioscience

Atlas Venture

Nantahala Capital Management

Disc Medicine

	Dec '20	Dec '21	Dec '22	Dec '23
account payables	4.65K -	2.56M 54,896.78%	16.16M 531.57%	12.63M 21.86%
accumulated other comprehensive income loss
cash and cash equivalents	1.21M -	88.04M 7,163.19%	194.61M 121.06%	360.38M 85.18%
cash and short term investments	1.21M -	88.04M 7,163.19%	194.61M 121.06%	360.38M 85.18%
common stock	112.27M -	1K 100.00%		2K -
deferred revenue		4.10M -		-13.29M -
deferred revenue non current
deferrred tax liabilities non current
goodwill
goodwill and intangible assets
intangible assets
inventory
long term debt		1.33M -	1.03M 23.01%	1.44M 39.82%
long term investments
net debt	-1.21M -	-86.38M 7,026.82%	-193.28M 123.74%	-358.28M 85.37%
net receivables
other assets
other current assets		3.47M -	198.49M 5,615.26%	5.28M 97.34%
other current liabilities	592.91K -	6.45M 987.85%	6.11M 5.29%	21.44M 250.94%
other liabilities
other non current assets	120.75M -	180K 99.85%	116K 35.56%	234K 101.72%
other non current liabilities		141.86M -
othertotal stockholders equity	5.81M -	1.19M 79.61%	288.81M 24,272.49%	533.76M 84.81%
preferred stock			2K -
property plant equipment net		1.75M -	1.60M 8.53%	2.10M 31.41%
retained earnings	-812.50K -	-65.39M 7,947.93%	-112.22M 71.61%	-188.65M 68.11%
short term debt		319K -	307K 3.76%	665K 116.61%
short term investments
tax assets
tax payables	100.32K -
total assets	122.09M -	92.41M 24.31%	200.21M 116.65%	368.00M 83.81%
total current assets	1.34M -	90.48M 6,662.47%	198.49M 119.37%	365.66M 84.22%
total current liabilities	597.57K -	13.42M 2,146.45%	22.58M 68.19%	21.44M 5.04%
total debt		1.65M -	1.33M 19.30%	2.10M 57.50%
total investments
total liabilities	4.82M -	156.61M 3,146.68%	23.61M 84.93%	22.88M 3.09%
total liabilities and stockholders equity	122.09M -	92.41M 24.31%	200.21M 116.65%	368.00M 83.81%
total non current assets	120.75M -	1.93M 98.40%	1.71M 11.05%	2.33M 36.17%
total non current liabilities	4.23M -	143.19M 3,288.11%	1.03M 99.28%	1.44M 39.82%
total stockholders equity	117.27M -	-64.20M 154.75%	176.60M 375.07%	345.12M 95.43%

COM:DISCMEDICINE

Disc Medicine, Inc.

Last Close

63.51

22/11 17:29

Market Cap

1.89B

Beta: -

Volume Today

63.32K

Avg: -

Preview